• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性心力衰竭中的气体扩散与肺泡-毛细血管单位

Gas diffusion and alveolar-capillary unit in chronic heart failure.

作者信息

Agostoni Piergiuseppe, Bussotti Maurizio, Cattadori Gaia, Margutti Eliana, Contini Mauro, Muratori Manuela, Marenzi Giancarlo, Fiorentini Cesare

机构信息

Centro Cardiologico Monzino, IRCCS, Istituto di Cardiologia, Università di Milano, via Parea 4, 20138 Milan, Italy.

出版信息

Eur Heart J. 2006 Nov;27(21):2538-43. doi: 10.1093/eurheartj/ehl302. Epub 2006 Oct 6.

DOI:10.1093/eurheartj/ehl302
PMID:17028107
Abstract

AIMS

Alveolar gas diffusion (DLCO) is impaired in chronic heart failure (CHF). Diffusion depends on membrane diffusion (DM) and the amount of blood participating in gas exchange (VC). How DM, VC, and the alveolar-capillary unit behave in relationship to CHF severity is unknown.

METHODS AND RESULTS

We measured pulmonary function, including DLCO, DM, VC, and alveolar volume (VA), in 191 CHF patients in NYHA class I-III. CHF patients were grouped accordingly to peak exercise oxygen uptake (pVO(2)): group <12 mL/min/kg (n=24), group 12-16 (n=76), group 16-20 (n=64), and group >20 (n=27). DLCO, DM, VC, and VA were lowest in severe CHF and were linearly related to pVO(2) (DLCO, r=0.577, P<0.001; DM, r=0.490, P<0.001; VC, r=0.216, P<0.01; VA, r=0.565, P<0.01). DM/VC ratio, an index of the alveolar-capillary unit efficiency, was higher in group <12 (0.49+/-0.39 mL/min/mmHg/mL) and >20 (0.46+/-0.29), compared with 12-16 (0.34+/-0.19) and 16-20 (0.35+/-0.17).

CONCLUSION

DLCO progressively worsens as CHF severity increases due to reduction in lung tissue participating to gas exchange (low VC and VA). In severe CHF, the few working alveolar-capillary units are the most efficient as shown by the high DM/VC. This is useful for maintaining gas exchange efficiency in severe CHF.

摘要

目的

慢性心力衰竭(CHF)患者存在肺泡气体扩散(DLCO)受损的情况。气体扩散取决于膜扩散(DM)和参与气体交换的血量(VC)。目前尚不清楚DM、VC以及肺泡 - 毛细血管单位在CHF严重程度方面的表现。

方法与结果

我们对191例纽约心脏协会(NYHA)心功能I - III级的CHF患者进行了肺功能测量,包括DLCO、DM、VC和肺泡容积(VA)。CHF患者根据峰值运动摄氧量(pVO₂)进行分组:<12 mL/min/kg组(n = 24)、12 - 16组(n = 76)、16 - 20组(n = 64)和>20组(n = 27)。严重CHF患者的DLCO、DM、VC和VA最低,且与pVO₂呈线性相关(DLCO,r = 0.577,P < 0.001;DM,r = 0.490,P < 0.001;VC,r = 0.216,P < 0.01;VA,r = 0.565,P < 0.01)。与12 - 16组(0.34 ± 0.19)和16 - 20组(0.35 ± 0.17)相比,<12组(0.49 ± 0.39 mL/min/mmHg/mL)和>20组(0.46 ± 0.29)的DM/VC比值(肺泡 - 毛细血管单位效率指标)更高。

结论

由于参与气体交换的肺组织减少(低VC和VA),随着CHF严重程度增加,DLCO逐渐恶化。在严重CHF中,少数仍在工作的肺泡 - 毛细血管单位效率最高,如高DM/VC所示。这有助于维持严重CHF时的气体交换效率。

相似文献

1
Gas diffusion and alveolar-capillary unit in chronic heart failure.慢性心力衰竭中的气体扩散与肺泡-毛细血管单位
Eur Heart J. 2006 Nov;27(21):2538-43. doi: 10.1093/eurheartj/ehl302. Epub 2006 Oct 6.
2
Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.血管紧张素转换酶抑制通过改善分子跨肺泡毛细血管膜的扩散,恢复慢性心力衰竭患者的一氧化碳弥散能力。
Clin Sci (Lond). 1999 Jan;96(1):17-22.
3
Reduced rate of alveolar-capillary recruitment and fall of pulmonary diffusing capacity during exercise in patients with heart failure.心力衰竭患者运动期间肺泡-毛细血管募集率降低及肺弥散能力下降。
J Card Fail. 2006 May;12(4):299-306. doi: 10.1016/j.cardfail.2006.01.010.
4
[Effects of cardiomegaly on the anatomical and functional state of the lung in chronic heart failure].[心脏肥大对慢性心力衰竭患者肺部解剖及功能状态的影响]
Cardiologia. 1998 Mar;43(3):295-301.
5
[Change of pulmonary diffusing capacity, membrane diffusing capacity and pulmonary capillary blood volume in patients with COPD and connective tissue disease at rest and post-exercise].[慢性阻塞性肺疾病和结缔组织病患者静息及运动后肺弥散能力、膜弥散能力和肺毛细血管血容量的变化]
Zhonghua Jie He He Hu Xi Za Zhi. 1998 Jun;21(6):344-7.
6
Alveolar--capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure.肺泡-毛细血管膜气体传导率:慢性心力衰竭的一种新型预后指标。
Eur Heart J. 2002 Mar;23(6):467-76. doi: 10.1053/euhj.2001.2803.
7
Sildenafil improves the alveolar-capillary function in heart failure patients.西地那非可改善心力衰竭患者的肺泡-毛细血管功能。
Int J Cardiol. 2008 May 7;126(1):68-72. doi: 10.1016/j.ijcard.2007.03.118. Epub 2007 May 8.
8
Decrease by ACE-inhibition of the excessive alveolar-capillary membrane resistance to gas transfer in chronic heart failure.在慢性心力衰竭中,通过血管紧张素转换酶抑制作用降低过度的肺泡-毛细血管膜对气体交换的阻力。
Cardiologia. 1998 Jun;43(6):625-30.
9
Effect of circulatory congestion on the components of pulmonary diffusing capacity in morbid obesity.循环充血对病态肥胖患者肺弥散能力各组成部分的影响。
Obesity (Silver Spring). 2006 Jul;14(7):1172-80. doi: 10.1038/oby.2006.134.
10
Impedance to gas transfer across the alveolar-capillary membrane in chronic cardiac failure.慢性心力衰竭时气体通过肺泡-毛细血管膜的转移阻抗。
Ital Heart J. 2000 Mar;1(3):169-73.

引用本文的文献

1
Dose-response relationship between Life's Essential 8 score and COPD risk: the NHANES cohort study 2007-2018.生命必需的八项指标得分与慢性阻塞性肺疾病风险之间的剂量反应关系:2007 - 2018年美国国家健康与营养检查调查队列研究
Front Med (Lausanne). 2025 Jan 23;12:1446782. doi: 10.3389/fmed.2025.1446782. eCollection 2025.
2
Double gas transfer factors (DLCO-DLNO) at rest in patients with congenital heart diseases correlates with their ventilatory response during maximal exercise.先天性心脏病患者静息时的双气体转移因子(DLCO-DLNO)与其最大运动时的通气反应相关。
Int J Cardiol Congenit Heart Dis. 2022 Feb 19;8:100346. doi: 10.1016/j.ijcchd.2022.100346. eCollection 2022 Jun.
3
Yoga and Cardiovascular Diseases - A Mechanistic Review.
瑜伽与心血管疾病——一项机制综述
Int J Yoga. 2024 May-Aug;17(2):83-92. doi: 10.4103/ijoy.ijoy_55_24. Epub 2024 Sep 13.
4
Relationship of Pulmonary Vascular Structure and Function With Exercise Capacity in Health and COPD.健康与慢性阻塞性肺疾病中肺血管结构和功能与运动能力的关系
Chest. 2025 Feb;167(2):402-413. doi: 10.1016/j.chest.2024.09.027. Epub 2024 Oct 3.
5
Should routine pulmonary function tests be performed in patients with left ventricular dysfunction and/or congestive heart failure undergoing cardiac surgery?对于接受心脏手术的左心室功能障碍和/或充血性心力衰竭患者,是否应进行常规肺功能检查?
J Cardiothorac Surg. 2024 Aug 28;19(1):499. doi: 10.1186/s13019-024-02978-3.
6
Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE/VCO.症状性新冠后患者的肺泡毛细血管膜功能受损,VE/VCO 高。
Respir Res. 2024 Feb 8;25(1):82. doi: 10.1186/s12931-023-02602-3.
7
Comparison of Pirfenidone and Nintedanib: Post Hoc Analysis of the CleanUP-IPF Study.吡非尼酮和尼达尼布的比较:特发性肺纤维化清除研究的事后分析。
Chest. 2024 May;165(5):1163-1173. doi: 10.1016/j.chest.2023.11.035. Epub 2023 Nov 27.
8
Inflammation associated with lung function abnormalities in COVID-19 survivors.新冠肺炎幸存者肺部功能异常与炎症相关。
BMC Pulm Med. 2023 Jul 1;23(1):235. doi: 10.1186/s12890-023-02521-5.
9
Resting pulmonary function and artery pressure and cardiopulmonary exercise testing in chronic heart failure patients in Taiwan - a prospective observational cross-sectional study comparing healthy subjects and interstitial lung disease patients.台湾地区慢性心力衰竭患者的静息肺功能、动脉压和心肺运动试验——一项比较健康受试者和间质性肺疾病患者的前瞻性观察性横断面研究。
Ann Med. 2023 Dec;55(1):2228696. doi: 10.1080/07853890.2023.2228696.
10
Characteristics of cardiopulmonary exercise testing in patients with combined post- and pre-capillary pulmonary hypertension due to left heart disease.左心疾病所致的后和前毛细血管性肺动脉高压合并患者心肺运动试验的特点。
PLoS One. 2023 May 22;18(5):e0286057. doi: 10.1371/journal.pone.0286057. eCollection 2023.